Oncology Opens Clinical Articles & Analysis: Older
18 articles found
MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a crucial role in the regulation of gene expression. Their ability to modulate various biological processes makes them significant players in the field of molecular biology and medicine. Among the various tools utilized in research and therapeutic applications, miRNA mimics have emerged as powerful instruments for manipulating and ...
Medical advancement relies on clinical trials, which are essential for the development of safe and effective innovative treatments. However, the success and general applicability of these treatments heavily depend on the diversity of the participants involved¹?³. This blog explores the importance of achieving data diversity in clinical trials to enhance clinical trial results and ...
This white paper details a study by Predictive Oncology and UPMC Magee-Womens Hospital. By combining the assets and domain expertise of both organizations, this collaboration aimed to improve ovarian cancer prognosis and treatment through accurate patient stratification and survival outcome predictions. Background and objective High grade serous carcinoma (HGSC) of the ovary is a complex and ...
The following patient case demonstrates the application of Adaptiiv’s technology used in clinical radiation oncology through the design and fabrication of customized bolus to improve the efficacy of treating complex target volumes with electron beams. This case is a great example of how a custom modulated electron bolus (MEB) allowed for a uniform dose distribution of a complex treatment ...
Navigating Cancer, Chief Clinical & Strategy Officer, Dr. Amila Patel, PharmD, BCOP, recently presented data on key findings from a recent abstract with Duke Health revealing racial disparities among head and neck cancer populations at the 2022 American Society of Clinical Oncology conference. Our research, along with our partners at Duke Health, found there were significant health care ...
A cancer diagnosis is a life-changing event. The diagnosis alone is daunting and then suddenly you are faced with difficult decisions – decisions that may affect your care and quality of life. Cancer is a 24/7 diagnosis, it affects daily life and routines. Symptoms and side effects present themselves on their own schedule, not necessarily when it is convenient for you. Recognizing the ...
Some companies are analyzing real-world data to create “virtual patients” to help inform selection for clinical trials, while others are using AI to optimize the design of new biologics. ...
Just days before the sunset of the CMS Oncology Care Model, CMS announced its new Enhancing Oncology Model (EOM), the new value-based care oncology payment model. Rolled out as part of the Biden-Harris Administration’s Cancer Moonshot, the goal of EOM is to improve the experience of cancer patients, while advancing health equity and increasing access to care, as well as reducing Medicare ...
A study conducted under the Lung Cancer Master Protocol (Lung-MAP) found that when treated with a combination of ramuzumab (Cyramza) and Keytruda, Patients with advanced NSCLC whose cancer progressed during prior immunotherapy lived significantly longer than when treated with one of the current standard therapies for this cancer. The hazard ratio (80% confidence interval) for overall survival ...
Worldwide, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer deaths in women, with over 650,000 deaths in 2020.1,2 Human epidermal growth factor receptor 2 (HER2)-targeted agents have improved outcomes in HER2-positive breast cancer, but most patients in first-line therapy do not respond to current therapies, eventually relapse or develop ...
Navigating Cancer in collaboration with Texas Oncology executes large-scale patient engagement study revealing high digital health solution engagement while demonstrating the opportunity to increase support for diverse patient populations. Scientific and technological advancements have helped enhance cancer care and access to care. Indeed, an important silver lining in the pandemic has been the ...
Navigating Cancer is filling an important role in the healthcare community during a time that has placed tremendous pressure on healthcare providers to better support a growing and diverse patient population, outside-of-the-clinic. Digital health tools and remote symptom monitoring enable more efficient care delivery and improve patient outcomes – while providing actionable insights based ...
The digital pathology software company PathPresenter (Montville, New Jersey) and the precision oncology platform firm 4D Path have entered into a partnership that could improve the diagnostic accuracy of breast tumor profiling. PathPresenter has developed a digital workflow tool for clinicians, pathologists and pharma companies to aggregate medical data. ...
Dr. Kandace P. McGuire shares how 3D tomosynthesis assisted her during two cases (The Case of the Missing Magseed & Imaging a Bracketed Lesion). In addition, Dr. McGuire discusses how she evaluated the specimens in multiple ways using KUBTEC’s MOZART ...
In the developed world, 1 in 4 people die from cancer or cancer-related disease, and cancer accounts for 13% of deaths globally. Oncology is the fastest growing therapeutic area by revenue and number of clinical trials. There’s been a huge emphasis on developing new treatments to improve survival in patients with cancer, but these trials have become a costly undertaking for sponsor ...
New collaborative research from Queen’s University Belfast, the University of Split, Croatia and King’s College London has shown that the response to the outbreak of the coronavirus disease 2019 (COVID-19) is significantly affecting the treatment and care of patients with cancer. The research, recently published in the European Journal of Cancer, highlights how the repurposing of ...
A trial involving ovarian cancer patients at Guildford’s Royal Surrey Hospital (UK) has found they have a higher chance of having all the tumour removed when undergoing surgery using argon plasma. Patients who participated in the ‘PlasmaJet® in Ovarian Cancer Surgery’ feasibility study were given a preview of the results as part of Ovarian Cancer Awareness Month recently. ...
One more year, Villavaquerín‘s Town Council celebrates his patron saints´s fiesta in honor to Virgen de Prado from 2nd to 10th of September. As in previous years, the Charity March marks the preamble of fiesta which begins officially on Thursday, the 7th with the inaugural announcement. The goal of this IV edition of Villavaquerín’s Charity March is to collect ...